Influenza-Associated Encephalopathy With Elevated Antibody Titers to Pandemic (H1N1) 2009 Influenza

Abstract

Pandemic H1N1 influenza (pH1N1) has been associated with encephalopathy, but the role of adaptive immunity in disease pathogenesis remains unclear. A child presented with seizures 5 days after onset of respiratory symptoms with pH1N1, with no detectable virus in cerebrospinal fluid. The authors compared her serum cytokines and pH1N1 antibody titers to those of 22 children with pH1N1, seasonal influenza, or other respiratory viral infections. They also compared her cerebrospinal fluid biomarkers to those of 20 children with confirmed or probable central nervous system infection or viral infection without central nervous system involvement. Her serum antibody titers were several-fold higher, and levels of proinflammatory cytokines in cerebrospinal fluid and serum were lower than those of controls. Antibody titers in cerebrospinal fluid were undetectable. The delayed onset of neurologic manifestations, normal cytokine levels in serum and cerebrospinal fluid, markedly elevated hemagglutinating and neutralizing antibody titers, and absence of virus and antibodies in cerebrospinal fluid raise the possibility of a post-infectious autoimmune-mediated process.

Keywords

encephalopathy pandemic H1N1 antibodies influenza virus

Get full access to this article

View all access options for this article.

References

Centers for Disease Control and Prevention (CDC). Interim Guidance for the Detection of Novel Influenza A Virus Using Rapid Influenza Diagnostic Tests. Atlanta, GA: CDC; 2009. http://www.cdc.gov/h1n1flu/guidance/rapid_testing.htm. Accessed December 18, 2009.

Cutler J. , Schleihauf E. , Hatchette TF , et al. Investigation of the first cases of human-to-human infection with the new swine-origin influenza A (H1N1) virus in Canada. CMAJ. 2009;181(3-4): 159-163.

Rowe T. , Abernathy RA , Hu-Primmer J. , et al. Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. J Clin Microbiol . 1999;37(4):937-943.

Walls HH , Harmon MW , Slagle JJ , Stocksdale C. , Kendal AP Characterization and evaluation of monoclonal antibodies developed for typing influenza A and influenza B viruses. J Clin Microbiol. 1986;23(2):240-245.

Studahl M. Influenza virus and CNS manifestations. J Clin Virol. 2003;28(3):225-232.

Neurologic complications associated with novel influenza A (H1N1) virus infection in children-Dallas, Texas, May 2009. MMWR Morb Mortal Wkly Rep. 2009;58(28):773-778.

Webster RI , Hazelton B. , Suleiman J. , Macartney K. , Kesson A. , Dale RC Severe encephalopathy with swine origin influenza A H1N1 infection in childhood: case reports. Neurology. 2010;74: 1077-1078.

Salonen O. , Koshkiniemi M. , Saari A. , et al. Myelitis associated with influenza A virus infection. J Neurovirol. 1997;3(1):83-85.

Fujimoto Y. , Shibata M. , Tsuyuki M. , Okada M. , Tsuzuki K. Influenza A virus encephalopathy with symmetrical thalamic lesions . Eur J Pediatr. 2000;159(5):319-321.

10.

Kawada J. , Kimura H. , Ito Y. , et al. Systemic cytokine responses in patients with influenza-associated encephalopathy. J Infect Dis. 2003;188(5):690-698.

11.

Okamura H. , Tsutsui H. , Kashiwamura S. , Yoshimoto T. , Nakanishi K. Interleukin-18: a novel cytokine that augments both innate and acquired immunity . Adv Immunol. 1998;70: 281-312.

12.

von Giesen HJ , Jander S. , Koller H. , Arendt G. Serum and cerebrospinal fluid levels of interleukin-18 in human immunodeficiency virus type 1-associated central nervous system disease . J Neurovirol. 2004;10(6):383-386.

13.

Suzuki T. , Ishiguro A. , Shimbo T. Transient elevation of interleukin-16 levels at the initial stage of meningitis in children. Clin Exp Immunol. 2003;131(3):484-489.

14.

Reber L. , Da Silva CA , Frossard N. Stem cell factor and its receptor c-Kit as targets for inflammatory diseases . Eur J Pharmacol. 2006;533(1-3):327-340.

15.

Sainaghi PP , Collimedaglia L. , Alciato F. , et al. The expression pattern of inflammatory mediators in cerebrospinal fluid differentiates Guillain-Barre syndrome from chronic inflammatory demyelinating polyneuropathy. Cytokine. 2010;51:138-143.

16.

Luster AD Chemokines-chemotactic cytokines that mediate inflammation. N Engl J Med. 1998;338(7):436-445.

17.

Cameron CM , Cameron MJ , Bermejo-Martin JF , et al. Gene expression analysis of host innate immune responses during lethal H5N1 infection in ferrets. J Virol. 2008;82(22):11308-11317.

18.

Wierzba TF , Abdel-Messih IA , Gharib B. , et al. Campylobacter infection as a trigger for Guillain-Barre syndrome in Egypt. PLoS One. 2008;3(11):e3674.

19.

Dale RC , Church AJ , Surtees RA , et al. Encephalitis lethargica syndrome: 20 new cases and evidence of basal ganglia autoimmunity. Brain. 2004 ;127(pt 1):21-33.

20.

Toplak N. , Avcin T. Influenza and autoimmunity. Ann N Y Acad Sci. 2009;1173:619-626.

21.

Jang H. , Boltz D. , Sturm-Ramirez K. , et al. Highly pathogenic H5N1 influenza virus can enter the central nervous system and induce neuroinflammation and neurodegeneration. Proc Natl Acad Sci U S A. 2009;106(33):14063-14068.

22.

Laing P. , Knight JG , Hill JM , et al. Influenza viruses induce auto-antibodies to a brain-specific 37-kDa protein in rabbit. Proc Natl Acad Sci U S A. 1989;86(6):1998-2002.